Global HIV Antivirals Industry is on course to exceed US$ 47.0 Billion by 2032, driven by new treatment options and an escalating prevalence | FMI

HIV Antivirals Industry
HIV Antivirals Industry

The global HIV antivirals industry demand has witnessed a substantial surge, reaching a noteworthy worth of US$ 30.6 billion as of 2022, signaling a promising trajectory for the healthcare industry. Recent forecasts indicate an impressive leap, projecting the market to achieve an estimated value of US$ 47.0 billion by the conclusion of 2032. This projection underscores a steady Compound Annual Growth Rate (CAGR) of 4.4% in sales revenue over the next decade.

The steady rise in the global HIV antivirals market not only reflects advancements in pharmaceutical research and development but also signifies a growing commitment to enhancing healthcare solutions for individuals affected by HIV/AIDS worldwide.

Get your Sample Report with Latest Market Information! https://www.futuremarketinsights.com/reports/sample/rep-gb-15095

The landscape of HIV antivirals has witnessed substantial evolution, driven by groundbreaking research and development initiatives. This progress has not only elevated treatment efficacy but also enhanced patient convenience and adherence to therapeutic regimens.

“As the market continues to expand, the pursuit of advanced treatment modalities and the emphasis on accessibility and inclusivity remain pivotal,” states Future Market Insights. “The projected growth underscores the collective efforts towards innovation and the unwavering commitment to improve the quality of life for individuals affected by HIV.”

Factors contributing to this remarkable growth include a combination of increased awareness, expanding healthcare infrastructure, and ongoing research initiatives aimed at developing more effective and accessible treatment options for HIV.

The anticipated rise in the market for HIV antivirals not only signifies economic growth but also underscores the profound impact on public health worldwide. This trajectory positions the industry to address evolving challenges and emphasizes the importance of sustained investment in research and development.

Therefore, to capitalise on the rising demand for generic anti-HIV medications, major producers are doing so at a low cost. For example, cheaper generic versions of Lamivudine, Abacavir, and Efavirenz are available in the US than their branded equivalents. This is projected to generate a lucrative opportunity for producers of generic HIV antivirals to provide low- and middle-income people with access to affordable medical services.

Key Takeaways from Market Study:

  • Because of their ability to increase adherence to an HIV treatment regimen, fixed-dose combinations (FDCs) owned more than 83.2% of the market value in 2021.
  • Hospital pharmacies are the dominant sales channel for HIV antivirals, accounting for over 53.4% of the market in 2021, and are expected to increase at a CAGR of 4.5% over the next decade.
  • In 2021, the United States dominated the North American HIV antivirals market, with a total market share of around 96.8%.
  • Because of the increasing number of HIV patients in the country, India is likely to lead the growth in the South Asian market.

“With increasing awareness among the people about HIV causes and symptoms, the HIV antivirals market is set witness positive growth during the forecast period. Hence, key players are developing anti-HIC drugs vaccines to increase their revenue,” says an analyst of Future Market Insights.

For any Queries Related with the Report, Ask an Analyst! https://www.futuremarketinsights.com/ask-question/rep-gb-15095

Market Competition

Key Players:

  • Merck & Co., Inc.
  • Johnson & Johnson
  • Genetech, Inc.
  • Teva Pharmaceutical Industries Ltd.
  • AbbVie
  • Cipla
  • Pfizer Inc.
  • Mylan N.V.

Market players are expanding the business through collaborations, and increasing involvement in clinical trials as the key strategy with instances of key companies, such as Merck and Gilead, in order to improve their reach in the market and compete with other key players in forthcoming years. For instance:

  • Merck reported positive results from two pivotal Phase 3 trials of the experimental, once-daily oral fixed-dose combination tablet of doravirine/islatravir (DOR/ISL) in adults with HIV-1 infection in October 2021.
  • Gilead announced in March 2021, in collaboration with Merck, the development and marketing of long-acting, experimental therapy combinations of Lenacapavir and Islatravir in HIV.

Customize Your Knowledge: Unlock Targeted Insights to Drive Growth in the HIV Antivirals Market! https://www.futuremarketinsights.com/customization-available/rep-gb-15095

Key Market Segments Covered in HIV Antivirals Market Research

By Product:

  • Fixed Dose Combinations (FDCs)
  • Integrase Strand Transfer Inhibitors (INSTIs)
  • Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)
  • Entry Inhibitors – CCR5 co-receptor antagonist
  • Protease Inhibitors (PIs)
  • Nucleoside Reverse Transcriptase Inhibitors (NRTIs)
  • Others

By Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Nandini Singh Sawlani   

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Rare Neurological Disease Treatment Market Sets Sights on a US$ 19.795 Billion Horizon by 2032-FMI Projection

Rare Neurological Disease Treatment Market
Rare Neurological Disease Treatment Market

Because there is currently little to no money available for research on the pathophysiology of rare diseases and a dearth of representative patient population, most rare diseases lack adequate diagnostic and therapeutic protocols.One of the most prevalent categories of uncommon diseases, rare neurological disease treatment market have inadequate diagnosis and therapy options. A rare neurological condition will be diagnosed in one out of every ten persons at some point in their lives, according to the WHO. The prevalence of neurological diseases is thought to be mostly determined by brain diseases, and the only method to avoid or lessen long-term morbidity and related healthcare expenditures is by early intervention.By 2032, the market is probably going to surpass US$ 19.795 million.

New Drug Formulations and Initiatives toward Improving Treatment & Care of Patients to Influence Market Growth

Declining blockbuster drugs have led pharmaceutical companies to keenly investigate potential new areas of research & development. Drug manufacturers have been incentivized by the Orphan Drug Act to develop new drug formulations associated with treatment of various rare diseases such as rare neurological diseases, in a bid to introduce new treatment options to the market. Regulatory advantages such as breakthrough designations, longer market exclusivity, and reduced fees & tax incentives have encouraged investments in R&D of drugs related to rare neurological diseases.

Get a Sample Copy of the Report : https://www.futuremarketinsights.com/reports/sample/rep-gb-6445

The world is entering into a new era, wherein science has realized the capability of aiding development of treatment & care for patients affected with rare neurological conditions. Several initiatives are being taken for coordinating efforts of pharmaceutical companies and healthcare institutes who share similar aim of improving treatment & care for patients suffering from rare neurological diseases.

For example, Brains for Brain Foundation, European Brain Council, LSD Patient Collaborative, and members of pharma industry are supporting an initiative in Europe which is expected to enhance visibility, awareness and recognition of rare neurological disorders for facilitating their early diagnosis. The initiative also aims to facilitate and promote collaboration and partnership between physicians, patient advocates, decision- & policy-makers, and researchers.

North America to Lead Global Rare Neurological Disease Treatment Market

North America is set to lead the global rare neurological disease treatment market, with an estimated revenue share of over 40% during 2017 to 2026. Economic and technological vigour, coupled with increasing geriatric population in the region, which is highly prone to such brain-related diseases, will influence demand for rare neurological disease treatment in North America.

The market revenue share of Europe and Asia-Pacific excluding Japan will also remain significant. However, combined revenues from the markets in these two regions will continue to be smaller than those amassed from the market in North America. Rare neurological disease treatment market in North America and Europe will record a parallel expansion through 2026, in terms of value.

Biologics to Remain Preferred Drug for Rare Neurological Disease Treatment

Biologics will continue to be the preferred drug for treatment of rare neurological diseases. Revenues from sales of biologics will account for the lion’s share of the market through the forecast period, based on drug type. However, revenues from sales of organic compounds for rare neurological disease treatment are forecast to record a relatively faster growth through 2026.

With an estimated market revenue share of nearly 60% during 2017 to 2026, Alzhiemer’s disease will continue to dominate the market, based on indication. In addition, revenues from treatment of this indication segment are likely to record the fastest rise in the market through 2026. Injectables will remain sought-after among mode of administration of drugs for treating rare neurological conditions.

Since the recent past, leading pharmaceutical companies have been placing more emphasis on rare disease, with tremendous support from the government. There is a greater likelihood that effective therapeutic measures for these life threatening rare diseases will be realized in the near future.

Key Players:

  • EMD Serono, Inc.
  • Jazz Pharmaceuticals
  • Teva Pharmaceutical Industries Limited
  • Johnson & Johnson
  • Sanofi
  • Medtronic Plc
  • Bayer Aktiengesellschaft
  • Novartis AG.

Key Segments :

By Vehicle Type:

  • Passenger cars
  • Light commercial Vehicles
  • Heavy Commercial Vehicles

By Fuel Type:

  • Petrol
  • Diesel

By Tuning stage:

  • Stage 1
  • Stage 2
  • Stage 3

By Tuning Method:

  • OBD Ports
  • Bench Tuning

By Application:

  • Racing
  • Fuel Economizing
  • Performance tuning

By Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia & Pacific
  • Middle East & Africa

Author By:

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:       

Nandini Singh Sawlani   

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Structural Adhesive Industry: Projecting Strong Growth with a 4.8% CAGR Throughout the Forecast Period 2033

The structural adhesives industry is poised for substantial growth, with a projected value of US$ 12,276.7 million in 2023, set to escalate to US$ 19,619.8 million by 2033, driven by a noteworthy Compound Annual Growth Rate (CAGR) of 4.8%. This surge can be attributed to the increasing utilization of structural adhesives across diverse applications in the automotive sector and advancements in adhesive product manufacturing technology. The global market’s expansion is fueled by the demand for innovative adhesive solutions, reflecting the industry’s response to evolving needs in various end-use sectors.

Furthermore, rising demand for structural adhesives in the construction sector for applications such as kitchen interiors, roofing, window panels, and wall coverings is propelling the global structural adhesives market forward.

Request Your Sample Report Now! https://www.futuremarketinsights.com/reports/sample/rep-gb-2667

Rising government infrastructure and redevelopment projects, particularly in emerging economies, are expected to drive growth in the global structural adhesives market during the forecast period.

The global market for structural adhesives is growing, but it is being constrained by strict regulations put in place by regulatory agencies to prevent harmful environmental consequences from structural adhesives.

For companies in the global structural adhesives market, increasing research and development efforts for the creation of safe, environmentally friendly structural adhesives with little to no environmental impact can open up profitable opportunities.

Key Takeaways from the Structural Adhesives Market

  • The segment for polyurethanes is anticipated to experience the highest CAGR growth of 5.1% during the forecast period. The growth is attributed towards its uses in various end user industries.
  • With a revenue share of over 25.0% in 2021, the building and construction sector had the greatest revenue share. Construction expenditures are predicted to rise as a result of economic development and population growth.
  • The Asia Pacific area had the largest percentage of almost 30% in terms of revenue in 2021. Its expansion is due to a surge in construction activity in countries including China, India, Japan, South Korea, and Indonesia.
  • U.S. will generate revenue of USD 4.2 Bn by 2033 due to the rise in construction and building maintenance activity.
  • About 35 to 40 percent of the demand is met by the top 6 to 8 companies. Small and medium-sized firms, which are gradually dispersing across the regions, collectively account for the remaining 60% of the market.
  • In terms of revenue share in 2021, Europe came in second. The construction industry is a significant contributor to the region’s GDP, accounting for around 9% of total product demand in this area.

Get the Report Methodology Now! https://www.futuremarketinsights.com/request-report-methodology/rep-gb-2667

Competitive Landscape

The presence of a sizable number of local and international companies across geographies is what distinguishes the fragmented global structural adhesive market. Important participants include 3M, Sika, Henkel, H.B. Fuller, and Arkema (Bostik).

The majority of major players are attempting to grow their businesses through lucrative alliances, acquisitions of small or mid-sized active vendors, or the acquisition of a specific adhesive sector to increase their footprint across the globe.

  • Arkema completed the acquisition of Ashland’s Performance Adhesives division in February 2022. Structural adhesives are among the products available under this division. The acquisition was worth USD 1.65 billion. The acquisition supported Arkema’s strategy to become a pure speciality material provider by 2024 and strengthened the company’s Adhesive Solutions division.
  • DuPont said in May 2021 that it will increase the output of its high-performance automobile adhesives at its manufacturing facilities in Germany and Switzerland by investing USD 5 million in capital and operating resources. This facility is planned to advance the production of the company’s goods, including BETAFORCE TC, BETATECH, BETAMETA, and BETASEAL.

Prepare your business for future expansion with a custom report catered to your unique requirements. Request yours now! https://www.futuremarketinsights.com/customization-available/rep-gb-2667

Key Segments in the Structural Adhesives Industry

Structural Adhesives Market by Product Type:

  • Epoxy-based Structural Adhesives
    • One Component
    • Two Component
  • Acrylic-based Structural Adhesives
  • Polyurethane-based Structural Adhesives
  • Cyanoacrylates
  • Others

Structural Adhesives Market by Application:

  • Structural Adhesives for Transportation Sector
    • Structural Adhesives for Automotive Sector
    • Structural Adhesives for Aerospace Sector
    • Structural Adhesives for Marine Sector
  • Structural Adhesives for Building & Construction Sector
  • Structural Adhesives for Energy Sector
  • Others

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia & Pacific
  • East Asia
  • Middle East & Africa (MEA)

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:       

Nandini Singh Sawlani  

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Anticipating Robust Growth: Metallic Stearate Industry Set to Achieve a 5.4% CAGR through 2033

The metallic stearate industry is poised for substantial growth, projected to reach US$ 630.19 million in 2023 and soar to US$ 1,066.29 million by 2033, reflecting a noteworthy Compound Annual Growth Rate (CAGR) of 5.4% during this period. Widely utilized across diverse industries such as plastics, pharmaceuticals, rubber, cosmetics, and the food sector, metallic stearates play a crucial role in various applications. The market’s trajectory is intricately linked to the performance and expansion of these industries, with any innovations or shifts in these sectors likely influencing the demand for metallic stearate.

Rubber has long used metallic stearate in the manufacture of rubber. Steel stearate are primarily used to prevent rubber from adhering to molds or to itself. Compounders have discovered that metal stearate have numerous physical and chemical properties that can be utilized. Leading players are also developing high-temperature-stable metallic stearate that will keep their color stability in thermoplastics despite their color or transparency. As a result of these developments, metallic stearate are expected to be used more frequently in metal processing and construction.

Transform Your Strategy: Request a Sample Report to Elevate Your Business! https://www.futuremarketinsights.com/reports/sample/rep-gb-3722

Regulations regarding chemical usage and safety standards can significantly influence the demand for metallic stearate. Manufacturers may have to reformulate their products if stricter regulations are placed on certain chemicals, which will affect the choices of additives. Technological advancements may enable metallic stearate to find new applications. Nanotechnology, for instance, could use metallic stearate to manufacture advanced materials. A growing number of industries are considering environmental factors. Metallic stearate may be considered less eco-friendly, which may lead to the search for more sustainable alternatives.

Key Takeaways

  • Zinc stearate is expected to reach a market share of 32.8% during the forecast period.
  • In 2033, polymers & plastics are expected to account for 32.1% of the market.
  • The metallic stearate market in India is predicted to expand at 6.5% CAGR until 2033.
  • Metallic stearate in the United Kingdom are expected to reach a CAGR of 3.9% during the forecast period.
  • A 4.9% CAGR is expected in the United States market for metallic stearate.

“Increasing research and development activities and increased personal care product demand drive metallic stearate demand. A growing focus on sustainable development and investments in new technologies will drive industry growth in the near future,” says Analyst at Future Market Insights (FMI).

Competitive Landscape

Several companies compete for metallic stearate in highly competitive industries. In recent years, niche industries targeting specific demographics have become increasingly popular. A strong partnership and innovation have contributed to the industry’s success. Recent years have seen a rapid increase in demand for Metallic Stearate in India.

Industry Developments Include

  • Baerlocher Group- Baerlocher produces metallic stearate around the world. Their product line includes calcium stearate, zinc stearate, and magnesium stearate, all of which are of high quality. Plastics, rubber, and construction industries all use these products.
  • Dover Chemical Corporation- Located in the United States, Dover Chemical manufactures metallic stearate, among other specialty chemical additives. Metallic stearate from their company are commonly used to enhance the processing and performance properties of plastics and rubber. Technical expertise and custom solutions are the hallmarks of Dover Chemical.
  • PMC Biogenix- PMC Biogenix specializes in producing metallic stearate and esters, as well as glycerides and glycerols. With a commitment to customer satisfaction and high-quality additives, the company is renowned for its high-quality products. 

Strategic Market Insights: Before Investing in the Metallic Stearate Industry, Talk to Our Experts to Learn How Different Regions and Countries Shape the Industry. Contact Us Now! https://www.futuremarketinsights.com/ask-question/rep-gb-3722

More Valuable Insights Available

Future Market Insights offers an unbiased analysis of the global market, providing historical data for 2018 to 2022 and forecast statistics from 2023 to 2033.

To understand opportunities in the metallic stearate market, the market is segmented based on Product Type (Zinc Stearate, Calcium Stearate, Magnesium Stearate, Aluminium Stearate, Others), Application (Polymers & Plastics Industry, Rubber Industry, Pharmaceuticals Industry, Personal Care & Cosmetics Industry, Construction Industry, Paints & Coatings Industry, Others), and Region (North America, Latin America, Western Europe, Eastern Europe, South Asia and Pacific, East Asia, Middle East, and Africa).

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:       

Nandini Singh Sawlani  

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Abdominal Closure Systems Industry exceeding US$ 293.72 Million by the year 2032, based on FMI’s projections

Abdominal Closure Systems Industry
Abdominal Closure Systems Industry

The global abdominal closure systems industry growth was valued at US$ 125.97 million in 2022 and is anticipated to grow by 8% CAGR to US$ 293.72 million by 2032.

It appears that abdominal compartment syndrome is one of the conditions that increases pressure inside the abdomen. Homeostasis in the patient is impacted by this. Negative effects may also occur to internal organs. Systems for abdominal closure are useful in this situation. The need for laparoscopic surgery is increasing, and trauma cases are increasing as well, therefore the future growth of the worldwide abdominal closure systems market is expected to be phenomenal.

Get a PDF Sample with Latest Market Insights! https://www.futuremarketinsights.com/reports/sample/rep-gb-9407

Damage control laparotomy, along with decompressive laparotomy, have turned out to be a part of armamentariums to treat complex abdominal trauma and profound acidosis (apart from abdominal compartment syndrome) since the last few years. However, it has been reported that these advances, along with saving lives, have resulted in increase in the number of patients with open abdominal cavities.

Combination of vacuum pack dressing (described by Barker), vicryl mesh closure systems, and commercially available VAC system is used as of now, as suggested by the University of Kentucky. Primary fascial closure rate is found to be 50%. A novel system listed by the US FDA, i.e. ABRA by Canica, is being introduced that makes use of progressive tension system as a new-fangled approach toward management of open abdomen. ABRA does provide dynamic reduction regarding retracted midline abdominal defects with the primary goal of restoration of primary closure. The subdermal method uses elastomer and button anchors for gradually pulling wound margins together. The tension could thus be set as well as adjusted as per the outcome desired; so as to stabilize retracted wound, close wound, reduce wound, or avert wound dehiscence.

It has been observed that traction abdominal closure systems are used in conjunction with NPWT, dynamic fascial suture, and sequential closure techniques for ascertaining a reliable and sturdy closure of abdominal wall.

With laparoscopy surgery in greater demand, the abdominal closure systems market is expected to grow on an exponential note in the forecast period. Besides, with minimally invasive surgery being increasingly preferred, abdominal closure systems are preferred for trocar and port sites after following laparoscopic procedures.

There are abdominal closure systems like ‘neoClose’ developed; which have a better output as compared to conventional closure methods. The trocar sites are being made available with various self-anchoring systems, thereby helping in doing away with need for retrievers or graspers. Teleflex and Medtronic are at the forefront regarding usage of abdominal closure systems.

Reach Out To Our Analyst For Prompt Assistance With Your Questions! https://www.futuremarketinsights.com/ask-question/rep-gb-9407

Future Market Insights has entailed these facts with insights in its latest market study entitled ‘Abdominal Closure Systems Market’. The line of expertise in the form of analysts and consultants is there with its 360-degree view regarding primary, secondary, and tertiary modes of research.

“Abdominal closing mechanisms are meant for the removal of abdominal walls like traction system. With these mechanisms being increasingly adopted, the global abdominal closure systems market is bound to grow graciously in the near future”, says an analyst from Future Market Insights.

Key Takeaways from Abdominal Closure Systems Market:

  • North America and Europe are at the matured stage of abdominal closure systems market. This could be attributed to rising adoption of advanced technology with respect to healthcare spending.
  • Coming to the Asia-Pacific, countries like India and China are witnessing rise in the number of cases pertaining to trauma along with increasing frequency of laparoscopic surgeries.

Competitive Systems:

  • Baxter International is shelling out a large chunk of money regarding research in this field; so as to obtain a competitive edge.
  • Medtronic has its absorbable sutures, nonabsorbable sutures, and V-Loc Wound Closure Device – barbed sutures.

For more Report Customization, connect with us at! https://www.futuremarketinsights.com/customization-available/rep-gb-9407

What does the Report say?

  • The report is categorized based on product type (laparoscopic abdominal closure devices and traction system), by indication (trauma surgery, laparoscopy, and transplantation surgery), and by end-use (hospitals, ambulatory surgical centers, and trauma & emergency centers).
  • With devices like dynamic tissue systems and ABRA abdominal doing the rounds, the global abdominal closure systems market is expected to go great guns in the forecast period.

 Key Companies Profiled:

  • ACell Inc.
  • neoSurgical
  • Teleflex Incorporated
  • Medtronic

Key Segments Profiled in the Abdominal Closure Systems Market Survey:

By Product Type:

  • Laparoscopic Abdominal Closure Devices
  • Traction System

By Indication:

  • Trauma surgery
  • Laparoscopy
  • Transplantation Surgery

By End Use:

  • Hospitals
  • Ambulatory Surgical Centers
  • Trauma & Emergency Centers

By Region:

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • Asia-Pacific excluding China and Japan
  • China
  • Japan
  • The Middle East and Africa

To Avail Discount on Report, Click! https://www.futuremarketinsights.com/checkout/9407

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Nandini Singh Sawlani   

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Rare Inflammatory Disease Treatment Market Soars to a Staggering US$ 17,335.8 Million Valuation by 2028-FMI Projection

Rare Inflammatory Disease Treatment Market
Rare Inflammatory Disease Treatment Market

The rare inflammatory disorders treatment market sales was valued at US$12,664 million in 2021; analysts expect it will increase at a rate of 4.6% between 2022 and 2028 to reach US$17,335.8 million.

The rare inflammatory disease treatment market has witnessed remarkable growth and innovation in recent years, owing to increasing awareness and advancements in medical research. Rare inflammatory diseases, often referred to as orphan diseases, affect a small percentage of the population and are characterized by their complexity and severity. This niche market has garnered significant attention from pharmaceutical companies and research institutions, leading to the development of targeted therapies and personalized treatment approaches. These treatments aim to alleviate symptoms, improve patients’ quality of life, and in some cases, offer potential cures for these debilitating conditions.

The emergence of precision medicine and breakthroughs in genetic research have played a pivotal role in driving progress within the rare inflammatory disease treatment market. Tailoring therapies to individual genetic profiles has shown promising results in managing and even reversing some of these diseases. Additionally, regulatory agencies have introduced incentives and fast-track processes to encourage the development of treatments for orphan diseases, further propelling investment and research in this space. As our understanding of these conditions deepens and treatment options expand, there is newfound hope for individuals and families affected by rare inflammatory diseases, underscoring the importance of continued investment and innovation in this vital healthcare sector.

Get a Sample Copy of the Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-6428

Key Takeways:

  1. Niche Market with High Unmet Needs: The rare inflammatory disease treatment market serves a small but underserved patient population. These diseases are often severe and can significantly impact patients’ lives, making the development of effective treatments crucial.
  2. Advancements in Precision Medicine: Advances in genetic research and precision medicine have opened up new avenues for understanding and treating rare inflammatory diseases. Tailored therapies based on individuals’ genetic profiles hold promise for more effective and personalized treatments.
  3. Increased Industry Interest: Pharmaceutical companies and research institutions have shown growing interest in this market due to its potential for innovation and addressing unmet medical needs. This interest has resulted in increased investment and research efforts.
  4. Regulatory Support: Regulatory agencies have introduced incentives and expedited approval processes for orphan disease treatments. This support encourages the development of therapies for rare inflammatory diseases and accelerates their availability to patients.
  5. Patient Advocacy: Patient advocacy groups and organizations play a significant role in raising awareness about rare inflammatory diseases. They also advocate for research funding and improved access to treatments, helping to drive progress in the field.
  6. Hope for Patients: The rare inflammatory disease treatment market offers hope to patients and their families by providing access to treatments that can alleviate symptoms, slow disease progression, or, in some cases, offer potential cures. Ongoing research and development efforts continue to improve the outlook for these individuals.

Key Companies:

  • Novartis AG
  • Abbvie Inc.
  • Abbott Laboratories
  • Regeneron Pharmaceuticals Inc.
  • Swedish Orphan Biovitrum AB
  • Pfizer, Inc.
  • Valeant Pharmaceuticals International Inc. (Bausch Health)
  • Mallinckrodt Plc.
  • Johnson & Johnson

Key Segments:

Rare Inflammatory Disease Treatment by Indication

  • RID Treatment for Ulcerative Colitis
  • RID Treatment Juvenile Rheumatoid Arthritis
  • RID Treatment Psoriatic Arthritis
  • RID Treatment Other Indications

Rare Inflammatory Disease Treatment by Drug Class

  • Biologics-based RID Treatment
  • Organic Compounds-based RID Treatment

Rare Inflammatory Disease Treatment by Mode of Administration

  • RID Injectables
  • Oral RID Treatment
  • Other RID Treatment Administration Modes

Rare Inflammatory Disease Treatment by Distribution Channel

  • RID Treatment through Hospital Pharmacies
  • RID Treatment through Retail Pharmacies
  • RID Treatment through Online Pharmacies

Rare Inflammatory Disease Treatment Market by Region

  • North America RID Treatment Market
  • Latin America RID Treatment Market
  • Europe RID Treatment Market
  • Asia Pacific RID Treatment Market
  • Middle East & Africa (MEA)

Elevate Strategy: Tap into Analyst Expertise Now:https://www.futuremarketinsights.com/ask-the-analyst/rep-gb-6428

Author By:

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Nandini Singh Sawlani   

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Rising Global Demand for Impact Modifiers Amidst Strained Public Transport Infrastructure: A Forecast for Significant Market Growth

The impact modifier market plays a crucial role in enhancing the performance and durability of various polymers, making them suitable for a wide range of applications. These modifiers are additives designed to improve the toughness and impact resistance of polymers, ensuring that the final products can withstand harsh conditions. As industries continue to innovate and demand high-performance materials, the impact modifier market has witnessed significant growth and evolution.

Request Sample: https://www.futuremarketinsights.com/reports/sample/rep-gb-7554

Key Market Drivers:

  1. Growing Demand in Construction Sector: The construction industry is a major driver of the impact modifier market. Impact modifiers are extensively used in the production of PVC (polyvinyl chloride), which is widely employed in construction materials such as pipes, fittings, and profiles. The increasing global focus on infrastructure development and urbanization has contributed to the rise in demand for impact modifiers.
  2. Expanding Automotive Sector: With a constant pursuit of lighter and more fuel-efficient vehicles, the automotive industry has become a prominent consumer of impact modifiers. These modifiers improve the impact resistance and weatherability of materials used in automotive interiors and exteriors, including dashboards, bumpers, and body panels.
  3. Rising Trends in Packaging Industry: The packaging industry has witnessed a surge in demand for impact modifiers, especially in the production of rigid packaging materials. These additives enhance the toughness of polymers used in packaging applications, ensuring that products remain intact during transportation and handling.
  4. Advancements in Material Science: Ongoing developments in material science have led to the introduction of innovative impact modifiers. Manufacturers are focusing on creating high-performance modifiers that not only enhance toughness but also offer other desirable properties such as UV resistance, chemical resistance, and flame retardancy.

Market Challenges:

  1. Environmental Concerns: The impact modifier market faces challenges related to environmental sustainability. As the industry continues to grow, there is an increasing emphasis on developing eco-friendly alternatives and addressing the environmental impact of certain modifiers.
  2. Volatility in Raw Material Prices: Fluctuations in the prices of raw materials, such as acrylics and styrenics, can impact the overall cost of impact modifiers. This volatility poses challenges for manufacturers in terms of maintaining stable pricing and profit margins.

Future Prospects:

The impact modifier market is poised for continuous growth, driven by the demand for high-performance materials in various industries. As technological advancements enable the development of more efficient and sustainable impact modifiers, the market is expected to witness increased innovation and collaboration within the industry.

Ask for Customization: https://www.futuremarketinsights.com/customization-available/rep-gb-7554

Key Segmentation of the Impact Modifier Market

Global Impact Modifier Market – By Product Type

  • ABS Impact Modifier
  • EPDM Impact Modifier
  • MBS Impact Modifier
  • ASA Impact Modifier
  • AIM impact Modifier
  • CPE Impact Modifier

Global Impact Modifier Market – By Application

  • PVC
  • Nylon
  • PBT
  • Engineering Plastic

Global Impact Modifier Market – By End Use

  • Packaging
  • Construction
  • Consumer Goods
  • Automotive

Global Impact Modifier Market – By Region

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • China
  • Japan
  • South-east Asia & rest of Asia Pacific
  • Middle East & Africa

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:       

Nandini Singh Sawlani  

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Telehealth Kiosks Industry is positioned for a noteworthy 12.79% CAGR uptick by 2032, according to FMI’s forecast

Telehealth Kiosks Industry
Telehealth Kiosks Industry

The global telehealth kiosk industry growth is expected to reach a value of US$ 12 billion globally in 2022 and is projected to increase at a CAGR of 12.79 % to reach a value of US$ 40 billion globally between 2022 and 2032. The way healthcare is accessible and provided is changing due to a significant revolution in the global telehealth kiosk market. These cutting-edge kiosks are turning into an essential part of contemporary healthcare ecosystems, providing a wealth of advantages that go far beyond typical medical settings.

The self-contained units known as telehealth Kiosks, telemedicine Kiosks, or healthcare Pods are furnished with cutting-edge technology and medical accessories. They reduce the need for physical appointments and lengthy wait periods by giving people easy access to healthcare services right away. These kiosks are thoughtfully positioned in a variety of venues, including pharmacies, retail establishments, workplaces, and educational institutions, improving accessibility to healthcare for a wide range of people.

Request a Sample copy of this Report! https://www.futuremarketinsights.com/reports/sample/rep-gb-8327

One of the primary advantages of Telehealth Kiosks is their ability to bridge the gap between patients and healthcare providers, particularly in underserved or remote areas. Patients can use these kiosks to consult with healthcare professionals via video calls, enabling timely diagnosis and treatment recommendations. This is especially crucial during emergencies and for managing chronic conditions where quick medical intervention can be life-saving.

Furthermore, Telehealth Kiosks offer a cost-effective solution for both patients and healthcare systems. They reduce the burden on overcrowded emergency rooms and clinics, leading to significant cost savings for healthcare providers. Patients benefit from reduced travel expenses, less time off work, and the ability to receive care without the need for a physical visit, enhancing overall affordability and accessibility.

Privacy and security are paramount in healthcare, and Telehealth Kiosks have integrated robust measures to ensure the confidentiality of patient information. Data encryption and stringent access controls protect sensitive medical data, instilling confidence in patients that their personal health information is safeguarded.

Key Takeaways:

  • The global telehealth kiosk market is expected to grow from US$ 12 billion in 2022 to US$ 40 billion by 2032, at a CAGR of 12.79%.
  • The growth of the telehealth kiosk market is being driven by rising healthcare costs, increasing demand for remote care, and growing adoption of telehealth by healthcare providers.
  • North America is expected to be the most lucrative market for telehealth kiosks during the forecast period.

Telehealth kiosks offer a number of benefits for both patients and healthcare providers. For patients, telehealth kiosks can provide convenient and affordable access to care. For healthcare providers, telehealth kiosks can help to improve patient outcomes and reduce costs.

The telehealth kiosk market is expected to continue to grow in the coming years, as more and more people adopt telehealth and healthcare providers look for ways to improve efficiency and reduce costs.

Should You Have Any Queries, Our Analyst Is Here To Assist You! https://www.futuremarketinsights.com/ask-question/rep-gb-8327

Key Companies Profiled:

  • American Well
  • Olea Kiosks Inc.
  • Computerized Screening Inc.
  • H & S Quality in Software SpA
  • AMD Global Telemedicine, Inc.
  • InTouch Health
  • Computerized Screening Inc.
  • ZIVELO Inc.

Key Segments Profiled in the Telehealth Kiosk Industry Survey:

Application:

  • Vital Signs Monitoring
  • Teleconsultation

End User:

  • Hospitals
  • Community Clinics
  • Pharmacies

Region:

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • Asia Pacific
  • Japan
  • Middle East & Africa

Empower Your Business with Customization: Discover the Strategies in Our New Report! https://www.futuremarketinsights.com/customization-available/rep-gb-8327

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Nandini Singh Sawlani   

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Orthodontic Wax Industry is gearing up for a notable breakthrough, aiming to reach US$ 2 Billion by the year 2032

Orthodontic Wax Industry
Orthodontic Wax Industry

The global orthodontic wax industry growth is anticipated to reach a value of about US$ 2 billion by 2032, growing at a CAGR of roughly 5% to 6% from 2022 to 2032.

In recent years, the global demand for orthodontic treatments has fueled continuous expansion and innovation in the orthodontic wax market. As it relieves the pain and irritability brought on by wires and brackets, orthodontic wax is an essential accessory for people undergoing orthodontic procedures, such as braces or clear aligners. This wax is a necessary tool for orthodontic patients of all ages because it is created from medical-grade components and is safe for oral usage.

Request A Report Sample To Gain Comprehensive Insights! https://www.futuremarketinsights.com/reports/sample/rep-gb-9099

One of the key factors contributing to the growth of the Orthodontic Wax Market is the rising awareness about oral health and the importance of orthodontic treatments. As more people seek orthodontic care to achieve a perfect smile and improve dental health, the demand for orthodontic wax has surged. Patients rely on orthodontic wax to alleviate sore spots and ulcers caused by braces or aligners, ensuring a more comfortable orthodontic journey.

Innovations in product formulations have also played a pivotal role in the market’s expansion. Manufacturers are continuously improving the quality and effectiveness of orthodontic wax, making it easier to use and longer-lasting. These advancements have not only enhanced the overall patient experience but have also increased the product’s popularity among orthodontic practitioners.

Moreover, the growing prevalence of orthodontic treatments among adults has further boosted the Orthodontic Wax Market. With an increasing number of adults opting for orthodontic procedures to correct misaligned teeth and enhance their smiles, the demand for orthodontic wax among this demographic has risen significantly. Adults appreciate the discreet nature of clear aligners and rely on orthodontic wax to minimize any discomfort during their treatment.

Key Takeaways: Orthodontic Wax Market:

  • The global orthodontic wax market is expected to reach US$ 2 billion by 2032, expanding at a CAGR of around 5% to 6% from 2022 to 2032.
  • The rising incidence of malocclusion and increasing demand for cost-effective orthodontic treatments are the key factors driving the growth of the orthodontic wax market.
  • Orthodontic wax is used to protect the lips, gums, and cheeks from irritation caused by braces or aligners.
  • Increasing awareness about oral health and the importance of orthodontic treatments is also fueling the demand for orthodontic wax.
  • Innovations in product formulations, such as longer-lasting and more comfortable waxes, are further boosting the market growth.
  • The growing prevalence of orthodontic treatments among adults is another key driver of the market.
  • North America is expected to remain the largest market for orthodontic wax throughout the forecast period, owing to the high prevalence of malocclusion and the high adoption of orthodontic treatments in the region.

Feel Free To Reach Out To Our Analyst For Any Queries You Might Have! https://www.futuremarketinsights.com/ask-question/rep-gb-9099

Orthodontic Wax Market: Competition Analysis:

The study bestows valuable insights into the competitive landscape of the global Orthodontic Wax market, by studying numerous players, their growth strategies, and key developments. The report dwells deep and studies different facets such as product launches, production methodologies, and steps adopted by players to make processes cost-effective, among others, are expected to influence their individual standpoint. Understanding the prevailing trends and strategies on the supply-side empowers players to foster their plan of action accordingly to progress on a remunerative path. Key players covered in the research include

  • Colgate-Palmolive Company
  • Pyrex Polymars
  • Metrodent Ltd.
  • DWS Systems
  • Bilkim Ltd

Orthodontic Wax Market: Segmentation

To simply the gargantuan study, the report is segregated on the basis of different segments.

By Product Type:

  • Beeswax
  • Paraffin Wax
  • Carnauba Wax

 By End Use:

  • Hospitals
  • Dental Clinics
  • Homecare Settings

Region:

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • Asia Pacific Excluding Japan (APEJ)
  • Japan
  • Middle East & Africa

Tailor-Made Solutions: Our Customization Report Reveals the Key to Success! https://www.futuremarketinsights.com/customization-available/rep-gb-9099

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Nandini Singh Sawlani   

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Smart Wheelchair Industry is forecasted to attain US$ 344.5 Million by 2032, growing steadily at a 7.8% CAGR, according to Future Market Insights

Smart Wheelchair Industry
Smart Wheelchair Industry

The global smart wheelchair industry demand is set to witness remarkable growth, projecting a promising CAGR of 7.8% from 2022 to 2032. The market, valued at US$ 162.6 Million in 2022, is expected to soar to an estimated value of US$ 344.5 Million by the end of 2032, showcasing an evolution in mobility solutions.

The surge in demand for assistive technologies has driven the propulsion of the smart wheelchair industry. With technological advancements at the forefront, the market is witnessing a transformative shift, empowering individuals with enhanced mobility and independence.

Get Recently Updated Report of Market as Sample Copy! https://www.futuremarketinsights.com/reports/sample/rep-gb-15035

Factors such as increased research and development initiatives, rising awareness about assistive technologies, and a growing aging population worldwide contribute significantly to this market’s expansion. These innovations not only offer improved maneuverability but also integrate smart features, ensuring safety and convenience for users.

The journey toward a more inclusive society is driven by technological advancements that break barriers and create opportunities for everyone. The anticipated surge in the smart wheelchair market reflects a promising future, underlining a commitment to fostering independence and mobility for all.

Patients may be relocated in hospital settings for procedures, tests, analysis, and consultations with outside experts. This is essential for persons whose lower limb limitations, soreness, fractures, or abnormalities make it difficult for them to move around or maintain their balance. Patients are currently taken to hospitals by patient transporters. A wheelchair might be used more frequently because of its independence, which would be better. As a result, there wouldn’t be any mistakes made because there wasn’t enough staff to finish the transfer.

Technological advancements are also shaping the growth of the smart wheelchairs industry for over a decade:

  • For instance, In November 2021, Sunrise Medical LLC. announced the launch of its new ZIPPIE® Sphynx™ an on the go, compact, easily transportable wheelchair that can fit within a compact car’s trunk according to the clients’ needs. The market is consolidated with a few key players dominating the industry.

Rising sedentary lifestyle, increasing popularity of ultra-lightweight smart wheelchairs, and increased focus on R&D for smart wheelchairs are some of the key trends of this market. The overall improved technology adoption globally will fuel the demand for smart wheelchairs and the market is likely to expand exponentially over the forecast period. (2022-2032)

In Case of Any Queries, Do not hesitate to Contact Our Analyst! https://www.futuremarketinsights.com/ask-question/rep-gb-15035

Key Takeaways from this study:

  • The joystick based smart wheelchairs hold the highest market share of about 85.0% during the year 2021, expanding at a CAGR of 7.6% during the forecast period.
  • Mobility impairment by usage accounts for the largest market value share of more than 40% and is set to expand at a CAGR of 7.2%.
  • The healthcare settings as the end users hold a market share of 48.0% in 2021 with an expected CAGR growth of 6.8% during the forecasted years.
  • North America is a leading region for the global smart wheelchairs market during the year 2021, accounting for a market share of 37.0%.

 “Growing patient awareness regarding smart wheelchairs would fuel the growth of this market globally” says an analyst of Future Market Insights.

Market Competition:

Acquisitions and expansion of existing facilities are some of the strategies adopted by leading manufacturers of the smart wheelchair industry such as Sunrise Medical and Permobil, to further their business and establish a stronger market presence.

  • In August 2020, Sunrise Medical announced the completion of a strategic acquisition of paediatric industry leaders, Leckey and Firefly, in order to extend its paediatric product and service portfolio.
  • In March 2022, Permobil, a leading player in the wheelchairs industry, announced an investment to expand their R&D and operations facility in Tennessee in order to expand their business.

Competitive Landscape:

Key players in the smart wheelchair industry are focusing on acquisitions to strengthen their market presence and expand into the global market. Keeping their sustainable development goals in mind, the companies also promote new product launches with the incorporation of an array of patient requirements.

Key Companies Profiled:

  • Medical Depot, Inc.
  • Permobil AB
  • Pride Mobility Products Ltd.
  • MEYRA GmbH
  • DEKA Research & Development Corp.
  • tmsuk company limited
  • Ottobock
  • WHILL Inc.
  • Invacare Corporation
  • Karman Healthcare, Inc.

Your Market, Your Insights: Request Customizations to Optimize Your Smart Wheelchair Market Approach! https://www.futuremarketinsights.com/customization-available/rep-gb-15035

Key Market Segments Covered in the Smart Wheelchair Industry Research:

By Product:

  • Joystick based Smart Wheelchairs
  • Bluetooth Connected Smart Wheelchairs

By Patient:

  • Mobility Impairment
  • Ocular Disability
  • Geriatric Group
  • Multiple-Disability
  • Others

By End-User:

  • Healthcare Settings
  • Home Care Settings
  • Public Access

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East & Africa

Gain Immediate Access to Detailed Market Insights: Purchase Now! https://www.futuremarketinsights.com/checkout/15035

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Nandini Singh Sawlani   

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube